Funding
Turn ideas into impact
Show Me
Due: January 7, 2028
Elucidating Immunometabolic Responses to HIV Infection that Increase TB or HBV Risk (R01 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-25-315
Due: January 7, 2028
Laboratories to Optimize Digital Health (R01 Clinical Trial Required)
Type
Grant
Source
Federal
Opp Number
PAR-25-136
Due: January 7, 2028
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 – Clinical Trial Not Allowed)
US $499,000
Type
Grant
Source
Federal
Opp Number
PAR-25-338
Due: January 7, 2028
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
PA-25-301
Due: January 7, 2028
Role of Defective Proviruses in HIV Persistence (R01 Clinical Trial Not Allowed)
US $500,000
Type
Grant
Source
Federal
Opp Number
PAR-25-330
Due: January 7, 2028
NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-25-234
Due: January 7, 2028
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 – Clinical Trial Optional)
US $499,000
Type
Grant
Source
Federal
Opp Number
PAR-25-337
Due: January 7, 2028
NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)
US $150,000
Type
Grant
Source
Federal
Opp Number
PAR-25-251
Due: January 7, 2028
Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-281
Submit your funding opportunity.
Do you have a grant, incentive, funding competition, or other funding source to share?